One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Racial Biology and Medical Misconceptions
Andrea Deyrup, M.D., Ph.D., and Joseph L. Graves, Jr., Ph.D.
doi : 10.1056/NEJMp2116224
Vol. 386 No. 6
Beyond Diversity — Time for New Models of Health
Jane L. Delgado, Ph.D.
doi : 10.1056/NEJMp2115149
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
Angélica Jayk Bernal, M.D., Monica M. Gomes da Silva, M.D., Dany B. Musungaie, M.D., Evgeniy Kovalchuk, M.D., Antonio Gonzalez, M.D., Virginia Delos R
doi : 10.1056/NEJMoa2116044
Cemented or Uncemented Hemiarthroplasty for Intracapsular Hip Fracture
Miguel A. Fernandez, Ph.D., Juul Achten, Ph.D., Nicholas Parsons, Ph.D., Xavier L. Griffin, Ph.D., May-Ee Png, Ph.D., Jenny Gould, Alwin McGibbon, B.A
doi : 10.1056/NEJMoa2108337
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
Lisa M. Dunkle, M.D., Karen L. Kotloff, M.D., Cynthia L. Gay, M.D., M.P.H., Germ?n ??ez, M.D., Jeffrey M. Adelglass, M.D., Alejandro Q. Barrat Hern?nd
doi : 10.1056/NEJMoa2116185
Survival with Cemiplimab in Recurrent Cervical Cancer
Krishnansu S. Tewari, M.D., Bradley J. Monk, M.D., Ignace Vergote, M.D., Austin Miller, Ph.D., Andreia C. de Melo, M.D., Ph.D., Hee-Seung Kim, M.D., Y
doi : 10.1056/NEJMoa2112187
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
Peter Schmid, M.D., Ph.D., Javier Cortes, M.D., Ph.D., Rebecca Dent, M.D., Lajos Pusztai, M.D., Ph.D., Heather McArthur, M.D., Sherko Kümmel, M.D., Ph
doi : 10.1056/NEJMoa2112651
Marginal-Zone Lymphomas
Davide Rossi, M.D., Ph.D., Francesco Bertoni, M.D., and Emanuele Zucca, M.D.
doi : 10.1056/NEJMra2102568
Molluscum Contagiosum
Rebecca F. Silverman, M.D., and Roman Shinder, M.D.
doi : 10.1056/NEJMicm2113300
Case 4-2022: A 55-Year-Old Man with Bilateral Hearing Loss and Eye Redness
Jeffrey P. Harris, M.D., Ph.D., Andrea L. Ciaranello, M.D., and Elisabeth S. Tabb, M.D.
doi : 10.1056/NEJMcpc2107349
Molnupiravir — A Step toward Orally Bioavailable Therapies for Covid-19
Richard Whitley, M.D.
doi : 10.1056/NEJMe2117814
How to Fill the Void — Bone Cement in Hemiarthroplasty
Cecilia Rogmark, M.D., Ph.D.
doi : 10.1056/NEJMe2119282
Audio Interview: Covid-19 as an Endemic Disease
Eric J. Rubin, M.D., Ph.D., Lindsey R. Baden, M.D., and Stephen Morrissey, Ph.D.
doi : 10.1056/NEJMe2201982
A Pernicious Cycle Affecting Premalignant Stem Cells
Nancy A. Speck, Ph.D.
doi : 10.1056/NEJMcibr2117528
Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial
doi : 10.1056/NEJMc2114046
Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction
doi : 10.1056/NEJMc2119225
